title: Drugs in liver disease and during albumin dialysis -MARS.
authors.affiliation: Department of Clinical Pharmacology, University of Rostock, Germany. jolanta.majcher-peszynska@medizin.uni-rostock.de
authors.forename: J
authors.initials: J
authors.lastname: Majcher-Peszynska
authors.forename: P
authors.initials: P
authors.lastname: Peszynski
authors.forename: S C
authors.initials: SC
authors.lastname: Müller
authors.forename: S
authors.initials: S
authors.lastname: Klammt
authors.forename: R
authors.initials: R
authors.lastname: Wacke
authors.forename: S
authors.initials: S
authors.lastname: Mitzner
authors.forename: J
authors.initials: J
authors.lastname: Stange
authors.forename: R
authors.initials: R
authors.lastname: Mundkowski
authors.forename: E M
authors.initials: EM
authors.lastname: Hehl
authors.forename: R
authors.initials: R
authors.lastname: Schmidt
authors.forename: B
authors.initials: B
authors.lastname: Drewelow
mesh_terms: D000900:Anti-Bacterial Agents / Q000493:pharmacokinetics / Q000627:therapeutic use; D001781:Blood Component Removal / Q000379:methods; D002442:Ceftazidime / Q000493:pharmacokinetics* / Q000627:therapeutic use; D002443:Ceftriaxone / Q000493:pharmacokinetics* / Q000627:therapeutic use; D005112:Extracorporeal Circulation / Q000379:methods*; D006801:Humans; D008107:Liver Diseases / Q000188:drug therapy / Q000378:metabolism*; D008657:Metabolic Clearance Rate; D015242:Ofloxacin / Q000493:pharmacokinetics* / Q000627:therapeutic use; D006435:Renal Dialysis / Q000379:methods*; D012709:Serum Albumin / Q000302:isolation & purification* / Q000378:metabolism*; D017334:Teicoplanin / Q000493:pharmacokinetics / Q000627:therapeutic use
chemical_list: D000900:Anti-Bacterial Agents; D012709:Serum Albumin; D017334:Teicoplanin; D002443:Ceftriaxone; D002442:Ceftazidime; D015242:Ofloxacin